Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $154.07M in the twelve months ending March 31, 2024, with 106.66% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.01M with 2.64% year-over-year growth. In the year 2023, Sutro Biopharma had annual revenue of $153.73M with 126.84% growth.

• Revenue (ttm): $154.07M
• Revenue Growth: +106.66%
• P/S Ratio: 2.00
• Revenue / Employee: $510,149
• Employees: 302
• Market Cap: 307.96M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	153.73M	85.96M	126.84%
Dec 31, 2022	67.77M	5.89M	9.52%
Dec 31, 2021	61.88M	19.16M	44.84%
Dec 31, 2020	42.72M	-14.00K	-0.03%
Dec 31, 2019	42.74M	4.32M	11.24%
Dec 31, 2018	38.42M	-13.32M	-25.75%
Dec 31, 2017	51.74M	-7.99M	-13.38%
Dec 31, 2016	59.73M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.